Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional Patent
01 août 2023 07h30 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...
MAPS Receives $5 Million Grant from the Steven & Alexandra Cohen Foundation
22 juin 2023 08h00 HE
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
SAN JOSE, Calif., June 22, 2023 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) today announced that the Steven & Alexandra Cohen Foundation has awarded MAPS...
Optimi Health To Supply MDMA For Therapist Experiential Training Program at Numinus, Supported by MAPS
15 juin 2023 09h40 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, June 15, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...
MAPS-Sponsored Global Psychedelic Survey Gathers Data for a Crucial View into Psychedelic Use
22 mai 2023 16h21 HE
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
SAN JOSE, Calif., May 22, 2023 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) announced the launch of the Global Psychedelic Survey. Co-sponsored by MAPS, SABI...
Have a Good Trip Benefit Show to Celebrate MAPS and Psychedelic Medicine
18 mai 2023 08h00 HE
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
The Flaming Lips, Eric Andre, and Reggie Watts to headline benefit show on Thursday, June 22, at the Mission Ballroom in Denver, Colorado, presented by Good Trip Studios + AEG RockiesPresale tickets...
GeoJunxion NV (ticker: GOJXN.AS) - Financiële en Operationele update 3de kwartaal (januari '23 - maart '23) en eerste 9 maanden van boekjaar 2022-23 (juli '22 - maart '23)
04 mai 2023 02h00 HE
|
GeoJunxion N.V.
GeoJunxion NV (ticker: GOJXN.AS) Financiële en Operationele update 3de kwartaal (januari '23 - maart '23) en eerste 9 maanden van boekjaar 2022-23 (juli '22 - maart '23) Belangrijkste punten: ...
GeoJunxion NV (ticker: GOJXN.AS) - Financial & Business update Q3 (January ‘23 - March ‘23) and first 9 months of F.Y. 2022-23 (July ‘22 - March ‘23)
04 mai 2023 02h00 HE
|
GeoJunxion N.V.
GeoJunxion NV (ticker: GOJXN.AS) Financial & Business update Q3 (January ‘23 - March ‘23) and first 9 months of F.Y. 2022-23 (July ‘22 - March ‘23) Key Facts: 60% revenue growth for the...
GeoJunxion (GOJXN.AS) en WizzyMaps kondigen samenwerking aan om state-of-the-art last-mile mapping en locatiediensten te leveren
06 avr. 2023 06h00 HE
|
GeoJunxion N.V.
Capelle aan den IJssel - 6 april 2023 - GeoJunxion (GOJXN.AS) is verheugd de samenwerking met WizzyMaps aan te kondigen voor het leveren van state-of-the-art last-mile mapping en locatiediensten. ...
GeoJunxion (GOJXN.AS) and WizzyMaps announce collaboration to deliver state-of-the-art last-mile mapping and location services
06 avr. 2023 06h00 HE
|
GeoJunxion N.V.
Capelle aan den IJssel, The Netherlands – 6 April 2023 – GeoJunxion (GOJXN.AS) is pleased to announce the collaboration with WizzyMaps to deliver state-of-the-art last-mile mapping and location...
Optimi Health Submits Phase I Clinical Trial Application Combining The Use Of Proprietary Psilocybin and MDMA Drug Candidates In Healthy Therapists
07 févr. 2023 10h31 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end Canadian-based drug manufacturer...